1024.54美元6.8(0.67%)
2025/06/20更新
績效 / 1月7.02%
3月3.66%
1年2.98%
晨星評等-
- 1.現金0.88%
- 2.股票9.88%
- 3.債券0.11%
- 4.其他89.13%
- 1.美國89.13%
- 2.歐元區3.76%
- 3.歐洲不包含歐元區2.39%
- 4.英國1.96%
- 5.加拿大1.77%
- 1.argenx SE ADR4.83%
- 2.Insmed Inc4.74%
- 3.Amgen Inc4.22%
- 4.Alnylam Pharmaceuticals Inc3.90%
- 5.Gilead Sciences Inc3.67%
- 6.Regeneron Pharmaceuticals Inc3.13%
- 7.Merus NV2.91%
- 8.TG Therapeutics Inc2.88%
- 9.Blueprint Medicines Corp2.78%
- 10.BridgeBio Pharma Inc2.66%
- 1.現金0.88%
- 2.股票9.88%
- 3.債券0.11%
- 4.其他89.13%
- 1.美國89.13%
- 2.歐元區3.76%
- 3.歐洲不包含歐元區2.39%
- 4.英國1.96%
- 5.加拿大1.77%
- 1.argenx SE ADR4.83%
- 2.Insmed Inc4.74%
- 3.Amgen Inc4.22%
- 4.Alnylam Pharmaceuticals Inc3.90%
- 5.Gilead Sciences Inc3.67%
- 6.Regeneron Pharmaceuticals Inc3.13%
- 7.Merus NV2.91%
- 8.TG Therapeutics Inc2.88%
- 9.Blueprint Medicines Corp2.78%
- 10.BridgeBio Pharma Inc2.66%